Azienda Ospedaliera Di Padova
Clinical trials sponsored by Azienda Ospedaliera Di Padova, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Pancreatic cancer study tracks why it comes back so fast after surgery Results expected Sep 2026 (estimated)
- New study explores surgery hope for inoperable pancreatic cancer Results expected Dec 2026 (estimated)
-
Cancer drug could ease rare nerve disorder
Disease control Recruiting nowThis study tests whether zanubrutinib, a drug used for certain blood cancers, can improve nerve function in people with anti-MAG neuropathy—a rare condition causing numbness, weakness, and balance problems. About 50 adults in Italy will take the drug for 12 months. Researchers wi…
Phase 2 • Sponsor: Azienda Ospedaliera di Padova • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New study explores surgery hope for inoperable pancreatic cancer
Knowledge-focused Recruiting nowThis study looks at patients with locally advanced pancreatic cancer that cannot be removed by surgery at first. After at least 4 months of chemotherapy, if the tumor shrinks enough, doctors may consider surgery. The goal is to see if this approach helps patients live longer and …
Sponsor: Azienda Ospedaliera di Padova • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC